Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1^G93A Mice that Model ALS

• Ching-Hua Lu,

  Affiliations Sobell Department of Motor Neuroscience and Movement Disorders, MRC Centre for Neuromuscular Disorders, UCL Institute of Neurology, University College London, London, United Kingdom, Trauma and Neuroscience Centre, Blizard Institute, Barts and The School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

  ⨯
• Axel Petzold,

  Affiliations Department of Neuroinflammation, UCL Institute of Neurology, University College London, London, United Kingdom, VU Medical Centre, Dept. of Neurology, Amsterdam, The Netherlands

  ⨯
• Bernadett Kalmar,

  Affiliation Sobell Department of Motor Neuroscience and Movement Disorders, MRC Centre for Neuromuscular Disorders, UCL Institute of Neurology, University College London, London, United Kingdom

  ⨯
• James Dick,

  Affiliation Sobell Department of Motor Neuroscience and Movement Disorders, MRC Centre for Neuromuscular Disorders, UCL Institute of Neurology, University College London, London, United Kingdom

  ⨯
• Andrea Malaspina,

  Affiliations Trauma and Neuroscience Centre, Blizard Institute, Barts and The School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, North-East London and Essex MND Care and Research Centre, London, United Kingdom

  ⨯
• Linda Greensmith

  * E-mail: l.greensmith@ucl.ac.uk

  Affiliation Sobell Department of Motor Neuroscience and Movement Disorders, MRC Centre for Neuromuscular Disorders, UCL Institute of Neurology, University College London, London, United Kingdom

  ⨯